News - CRTonline

News

1-20 of 4082 results
1 2 3 4 5 Next »

Discussion on Arrhythmia Monitoring After Stroke: ACC Expert Consensus

Dec 20, 2024 by
Bailey G. Salimes, CRTonline.org

Cardiac rhythm monitoring after stroke continues to be a topic of debate as improved monitoring strategies increase likelihood of arrhythmia detection post-stroke, but impacts on secondary stroke prevention are still unclear, reports an expert consensus.

Hypertension, Obesity Strong Risk Factors for New-Onset HF: U.K. Biobank Study

Dec 20, 2024 by
Bailey G. Salimes, CRTonline.org

Hypertension and obesity are the strongest risk factors for new-onset heart failure (HF) in both men and women, but women are still at greater risk than men, a new analysis of the U.K. Biobank shows.

Potential Risk Factors for Progressive Ascending Aorta Dilation in BAV Patients Undergoing TAVR Identified: Exploratory Analysis

Dec 16, 2024 by
Natalie Morrison, CRTonline.org

A subset of bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement may be at increased risk for progressive ascending aorta dilation, according to a new exploratory analysis of 61 patients.

Should Sex be a Factor in Deciding 3VD Patients’ Revascularization Strategy?

Dec 16, 2024 by
Natalie Morrison, CRTonline.org

Women with 3-vessel coronary artery disease have similar outcomes to men following placement of a drug-eluting stent using percutaneous coronary intervention but fare worse with coronary artery bypass grafting.

Revolutionary Study Maps Navitor Transcatheter Aortic Valve Geometry Using CT Imaging

Dec 09, 2024 by
Will Chu, CRTonline.org

In the first study of its kind, scientists have conducted a computed tomography (CT) analysis of the in vivo frame geometry of the Navitor intra-annular self-expanding valve (SEV).

NCL Location Makes No Difference in Outcomes of Complete Revascularization for STEMI with MVD: COMPLETE Trial Sub Analysis

Dec 09, 2024 by
Natalie Morrison, CRTonline.org

Complete revascularization, including both culprit and non-culprit lesions (NCLs), is beneficial for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease (MVD), regardless of NCL location, according to a new analysis of the COMPLETE trial.

AI-Enhanced Model Improves Cardiac Amyloidosis Diagnostics, Study Suggests

Dec 09, 2024 by
Will Chu, CRTonline.org

A study highlights the potential of a novel deep learning (DL) model that uses vision transformer (ViT) architecture to enhance the diagnostic accuracy of cardiac amyloidosis (CA) through cardiac magnetic resonance (CMR) imaging.

More Bleeds With CABG, but Greater Post-Discharge Risk for PCI in LMCAD Patients: EXCEL Analysis

Dec 02, 2024 by
Natalie Morrison, CRTonline.org

Left main coronary artery disease patients undergoing coronary artery bypass grafting in the EXCEL trial have higher 5-year major bleed rates than those on percutaneous coronary intervention (PCI), but PCI carries a greater risk of post-discharge bleeding.

Exercise Rehabilitation Should Become ‘Third Pillar’ in Stable Angina Treatment, Experts Urge

Dec 02, 2024 by
Natalie Morrison, CRTonline.org

Lifestyle interventions, including exercise-based cardiac rehabilitation (ExCR), should become the “third central pillar” in the treatment of stable angina, researchers have urged, following a review of Dutch public health insurance and studies in the field.

Experts Question Review Omission of Coronary Sinus Reducer for Angina Treatment

Dec 02, 2024 by
Will Chu, CRTonline.org

A recent letter published in the Journal of the American College of Cardiology calls for greater recognition of the Coronary Sinus Reducer (CSR) as an innovative therapy for patients with refractory angina.

Encouraging IVL Outcomes in ISR: NCDR Analysis

Nov 25, 2024 by
Natalie Morrison, CRTonline.org

Intravascular Lithotripsy (IVL) has demonstrated “encouraging” outcomes in off-label use for the treatment of in-stent restenosis (ISR), and warrants further studies to pin-down optimal use and long-term effects, according to a new research letter analyzing NCDR data.

Study Further Clarifies Distinction Between Fibrotic and Calcific Aortic Stenosis in TAVR Patients

Nov 25, 2024 by
Will Chu, CRTonline.org

Research published in JACC: Cardiovascular Interventions identifies the significant differences between fibrotic and calcific forms of aortic stenosis (AS), as researchers reveal further insights into patient characteristics and outcomes post-transcatheter aortic valve replacement (TAVR).

Better Outcomes for Dedicated Severe Native AR TAVR Devices Vs Off-Label: Meta-Analysis

Nov 25, 2024 by
Natalie Morrison, CRTonline.org

Dedicated transcatheter aortic valve replacement (TAVR) devices led to better outcomes in high-risk severe native aortic regurgitation (AR) patients than off-label alternatives, according to a new meta-analysis in more than 2,000 patients.

Study Identifies Similar One Year Outcomes for Two Transcatheter Heart Valves

Nov 25, 2024 by
Will Chu, CRTonline.org

A retrospective analysis finds no significant difference in key long-term outcomes between two advanced transcatheter heart valves in findings that provide critical insights for optimizing valve selection in transcatheter aortic valve replacement (TAVR) procedures.

Recurrent Rejection Raises Graft Rejection Risk in Pediatric Heart Transplant: PHTS Analysis

Nov 20, 2024 by
Natalie Morrison, CRTonline.org

Children who experience recurrent mixed or antibody-mediated rejection episodes of heart transplants face a higher risk of losing their graft, according to a new multi-institutional analysis.

Both Social and Genetic Factors Can Boost CHD Risk Prediction Accuracy: New AoU Analysis

Nov 19, 2024 by
Natalie Morrison, CRTonline.org

Both genetic and social factors should play a joint role in boosting the accuracy of risk modeling for coronary heart disease (CHD), said the authors of a new analysis of the ‘All of Us’ (AoU) program, stressing that racial identity is a crucial driver behind bigger social burden.

Halting HF Treatment Poses Risk of Rapid Health Decline, Review Warns

Nov 19, 2024 by
Will Chu, CRTonline.org

A recent review reveals the significant risks heart failure patients face if they discontinue long-term drug treatments, which can include a rapid return to baseline and worsening rebound.

Researchers Highlight Statistical Hurdles Hindering Mortality Reductions in HFmrEF and HFpEF Patients

Nov 19, 2024 by
Will Chu, CRTonline.org

A new article offers insight on the challenges of reducing mortality rates in patients with heart failure with mildly reduced ejection fraction (HFmrEF) and preserved ejection fraction (HFpEF).

Good Concordance Between Echo and CMR Reference, Study Reports

Nov 13, 2024 by
Nathan Gray, CRTonline.org

The quantitation of aortic regurgitation (AR) severity by transthoracic echocardiogram has good concordance against a cardiac magnetic resonance reference standard, according to a new analysis that also proposes simplified echo algorithms to evaluate significant and mild AR.

Time to Change the Guidelines? Early Echocardiographic Markers of Left Ventricular Dysfunction May Offer Survival Benefit

Nov 13, 2024 by
Nathan Gray, CRTonline.org

Patients with asymptomatic clinically significant chronic aortic regurgitation incur a survival penalty when Class I/IIa guideline recommendations are attained compared with patients who do not yet reach guideline status but do show early echocardiographic markers of early left ventricular dysfunction, new data suggests.

1-20 of 4082 results
1 2 3 4 5 Next »

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details